The miR-195 was significantly downregulated in patients with positive expression of ER [FC: 0.12 (range: 0–0.96)], relative to those with negative ER on the tumor cells [FC: 0.76 (range: 0.14–0.98), p < 0.001]. Here, ESR1 is linked to neoplasm.